0.757
0.01 (1.15%)
| Penutupan Terdahulu | 0.748 |
| Buka | 0.725 |
| Jumlah Dagangan | 9,643 |
| Purata Dagangan (3B) | 1,042,366 |
| Modal Pasaran | 8,103,988 |
| Harga / Jualan (P/S) | 59.33 |
| Harga / Buku (P/B) | 0.720 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -2,518.17% |
| EPS Cair (TTM) | -0.350 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 56.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 25.43% |
| Nisbah Semasa (MRQ) | 0.080 |
| Aliran Tunai Operasi (OCF TTM) | -1.07 M |
| Pulangan Atas Aset (ROA TTM) | -8.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -21.00% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Gelteq Limited | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.13 |
|
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 60.36% |
| % Dimiliki oleh Institusi | 1.11% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Wedbush Securities Inc | 31 Dec 2025 | 20,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |